Administration of an ACE-inhibitor or not ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 210 | Single Ventricle | 1 |
210. Single Ventricle
Clinical trials : 51 / Drugs : 53 - (DrugBank : 22) / Drug target genes : 32 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00263406 (ClinicalTrials.gov) | December 2002 | 4/12/2005 | Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation | Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation | Children With a Univentricular Heart Undergoing Surgery for Creation of a Fontan Circulation | Drug: Administration of an ACE-inhibitor or not | University Hospital, Ghent | NULL | Completed | 1 Month | 18 Years | Both | 40 | Phase 2 | Belgium |